Varda Space Industries

Mission success: Ritonavir crystallization experiments conducted in space worked flawlessly

Retrieved on: 
Vendredi, mars 22, 2024
Form, Mission, Spacecraft, Ritonavir, CSO, Varda Space Industries, Pharmaceutical industry

WEST LAFAYETTE, Ind., March 22, 2024 /PRNewswire-PRWeb/ -- Improved Pharma and Varda Space Industries have published the first mission results in ChemRxiv in an article entitled Return of the Ritonavir: A Study on the Stability of Pharmaceuticals Processed in Orbit and Returned to Earth. The team reports that the most stable form of ritonavir (Form II) was successfully converted to the metastable Form III in microgravity. In addition, control samples of Form I, Form II, Form III, and amorphous ritonavir that were also part of the payload were successfully recovered, with no signs of form conversion.

Key Points: 
  • The team reports that the most stable form of ritonavir (Form II) was successfully converted to the metastable Form III in microgravity.
  • In addition, control samples of Form I, Form II, Form III, and amorphous ritonavir that were also part of the payload were successfully recovered, with no signs of form conversion.
  • These results from Mission 1 show that the spacecraft and crystallization hardware performed flawlessly.
  • Analytical testing at Improved Pharma confirmed that the space crystallization experiments were a success, and that the physical stability of all samples was preserved.

Rocket Lab Unveils Spacecraft Bus Lineup

Retrieved on: 
Mardi, février 27, 2024
Satellite, Air, Technology, Aerospace, Transport, Manufacturing, Other Technology, Neutron, SSL (company), Annual report, NASA, Lab, GEO, Lightning, Carbon, Neo, Globalstar, University, Pioneer, Space Development Agency, Spacecraft, Family, Security (finance), Telecommunications, Exploration, Rocket Lab, MDA, LEO, Varda Space Industries, Communications satellite

Rocket Lab USA, Inc (Nasdaq: RKLB) (“Rocket Lab” or “the Company”), a leading launch and space systems company, today introduced its family of spacecraft buses, consolidating the custom designs Rocket Lab has developed for multiple customers and missions.

Key Points: 
  • Rocket Lab USA, Inc (Nasdaq: RKLB) (“Rocket Lab” or “the Company”), a leading launch and space systems company, today introduced its family of spacecraft buses, consolidating the custom designs Rocket Lab has developed for multiple customers and missions.
  • Photon was the start, but the Rocket Lab spacecraft family has grown,” said Rocket Lab founder and CEO Peter Beck.
  • “We’ve struck the right balance between commonality to deliver cost-effective, rapid production and ensuring our spacecraft are configurable to suit unique and specific mission profiles.”
    Rocket Lab’s family of spacecraft includes:
    Photon: The original Rocket Lab spacecraft, Photon is the Company’s integrated launch-plus-spacecraft solution.
  • To support the rapid production of our family of spacecraft, Rocket Lab has established an advanced spacecraft development and manufacturing complex at the Company’s Long Beach headquarters.

Rocket Lab Announces Fourth Quarter and Full Year 2023 Financial Results, Issues Guidance for the First Quarter 2024 Including Sequential Revenue Growth Greater than 50 Percent

Retrieved on: 
Mardi, février 27, 2024
Air, Technology, Satellite, Transport, Aerospace, Manufacturing, Neutron, SSL (company), Radar, Lab, Table, HASTE, Interest expense, Carbon, NorthStar, GAAP, Launch Complex 3, Tranche, Webcast, Space Development Agency, Electron, Launch, Rocket Lab, Varda Space Industries, Archimedes, Communications satellite

Rocket Lab founder and CEO, Peter Beck, said: “Rocket Lab had another strong year in 2023 across our launch and space systems businesses.

Key Points: 
  • Rocket Lab founder and CEO, Peter Beck, said: “Rocket Lab had another strong year in 2023 across our launch and space systems businesses.
  • It was also a record year for securing Electron and HASTE contracts, with 25 new orbital and suborbital missions signed in 2023.
  • Electron successfully returned to flight in the fourth quarter, deploying a synthetic aperture radar satellite to orbit for Japanese constellation operator iQPS.
  • ET) today to discuss these business highlights and financial results for our fourth quarter, to provide our outlook for the first quarter, and other updates.

Rocket Lab Successfully Returns Spacecraft Capsule to Earth, Brings Back Pharmaceuticals Made in Space

Retrieved on: 
Mercredi, février 21, 2024
Health, Communications, Satellite, Technology, General Health, Pharmaceutical, Public Relations, Investor Relations, Neutron, Multimedia, Ritonavir, Epidemic, NASA, Lab, Failure, Radio, Moon, Pandemic, Risk, Congestion, Orbit, Spacecraft, Electron, Security (finance), International Space Station, Rocket Lab, Varda Space Industries, UTTR, Environment, Transport

Rocket Lab designed, manufactured and operated a bespoke spacecraft to enable Varda’s capsule manufacturing demonstration.

Key Points: 
  • Rocket Lab designed, manufactured and operated a bespoke spacecraft to enable Varda’s capsule manufacturing demonstration.
  • The spacecraft included a full suite of Rocket Lab sub-systems and components built in-house, spanning spacecraft engine, flight software, avionics, reaction wheels, star trackers, capsule dispenser, solar panels, radio, composite structures and tanks, and more.
  • Rocket Lab also supported the mission with 24/7 satellite operations to return Varda’s capsule to Earth.
  • There can be no assurance that the future developments affecting Rocket Lab will be those that we have anticipated.

Improved Pharma analyzing pharmaceuticals crystallized in space

Retrieved on: 
Lundi, février 26, 2024
Soil, Ritonavir, Varda Space Industries, Research, Spacecraft, Partnership

WEST LAFAYETTE, Ind., Feb. 26, 2024 /PRNewswire-PRWeb/ -- Varda's satellite "Winnebago-1" was launched into space to demonstrate Varda's spacecraft & reentry capabilities and pharmaceutical hardware functionality, paving the way for microgravity-enabled drug development. While in low earth orbit, melt/cool experiments were successfully conducted on ritonavir. Varda's capsule successfully touched down in the Utah Desert at the Utah Test and Training Range on February 21st, 2024, marking the first time in our nation's history that a commercial entity landed a spacecraft on US soil. The pharmaceutical samples housed within the capsule are now with Improved Pharma for post-flight analysis and characterization.

Key Points: 
  • The pharmaceutical samples housed within the capsule are now with Improved Pharma for post-flight analysis and characterization.
  • The samples recovered from the spacecraft were received by a team of Improved Pharma and Varda scientists and engineers.
  • In 2021, Improved Pharma and Varda initiated a partnership focused on advancing pharmaceutical product development in microgravity.
  • Their first joint research project was published in 2022 and announced the discovery of a new form of ritonavir.

Rocket Lab Announces Second Quarter 2023 Financial Results, Issues Guidance For Continued Revenue Growth In Third Quarter 2023

Retrieved on: 
Mardi, août 8, 2023
Technology, Aerospace, Manufacturing, Satellite, Acceleration, NASA Launch Services Program, Table, Spire Global, Lab, Orbit, Launch Complex 2, Spacecraft, GAAP, Interest expense, EBITDA, SSL (company), Launch Complex 1, NASA, HASTE, Webcast, Growth, Varda Space Industries, Rocket Lab, TROPICS, Communications satellite, Clothing, Security (finance), Neutron, Electron, Spaceflight Industries, Virgin Orbit

Rocket Lab USA, Inc. (Nasdaq: RKLB) (“Rocket Lab” or “the Company”), a global leader in launch services and space systems, today shared the financial results for fiscal second quarter 2023, ended June 30, 2023.

Key Points: 
  • Rocket Lab USA, Inc. (Nasdaq: RKLB) (“Rocket Lab” or “the Company”), a global leader in launch services and space systems, today shared the financial results for fiscal second quarter 2023, ended June 30, 2023.
  • We also achieved some major development milestones for Neutron in the second quarter, including completion of the second stage qualification tank.
  • Strong quarter for space systems with Rocket Lab satellite components or software featured in 17 spacecraft launched to orbit.
  • ET) today to discuss these business highlights and financial results for our first quarter, to provide our outlook for the second quarter, and other updates.

Rocket Lab Spacecraft Built for Varda Successfully Operating on Orbit

Retrieved on: 
Mardi, juin 13, 2023
Technology, Air, Transport, Satellite, Other Technology, Aerospace, Manufacturing, Health, Pharmaceutical, Neutron, Varda Space Industries, Drug Quality and Security Act, Lab, Orbit, COVID-19, Electron, Spacecraft, Vandenberg Space Force Base, Epidemic, Pandemic, SSL (company), NASA, Risk, Security (finance), MDA, Rocket Lab, Environment, Software, Communications satellite, Mars, Moon, Rocket, Photon

Rocket Lab USA, Inc. (Nasdaq: RKLB) (“Rocket Lab” or “the Company”), a global leader in launch services and space systems, today announced its spacecraft for Varda Space Industries (“Varda”), a leading in-space manufacturing and hypersonic re-entry logistics company, is successfully operating on orbit after launching from Vandenberg Space Force Base today on SpaceX’s Transporter-8 mission at 14:35 PDT (21:35 UTC).

Key Points: 
  • Rocket Lab USA, Inc. (Nasdaq: RKLB) (“Rocket Lab” or “the Company”), a global leader in launch services and space systems, today announced its spacecraft for Varda Space Industries (“Varda”), a leading in-space manufacturing and hypersonic re-entry logistics company, is successfully operating on orbit after launching from Vandenberg Space Force Base today on SpaceX’s Transporter-8 mission at 14:35 PDT (21:35 UTC).
  • The spacecraft is the first of four ordered by Varda to support in-space pharmaceutical manufacturing, with the second spacecraft currently undergoing assembly, integration, and testing.
  • “From technology demonstration missions in low Earth orbit to complex missions to the Moon, and now in-space manufacturing, Rocket Lab spacecraft are enabling innovation on orbit.
  • Rocket Lab components and subsystems have been successfully flown on more than 1,000 spacecraft globally.

Improved Pharma and Varda Space Industries conducting pharmaceutical experiments in space

Retrieved on: 
Mercredi, juin 14, 2023
CNN, United States Air Force, Orbit, Varda Space Industries, Engineering, Convection, Growth, Ritonavir, Drug development, Acquisition, Crystallization, Research, Organic Process Research & Development

WEST LAFAYETTE, Ind., June 14, 2023 /PRNewswire-PRWeb/ -- On board the rocket launch for the Transporter-8 Mission sat Varda's satellite "W-Series 1". Within the capsule sits the drug ritonavir, created by scientists at Improved Pharma and housed in engineering designed and built by Varda to conduct controlled experiments in microgravity. A little over an hour after launch, the satellite was deployed and acquisition of signal followed shortly. While in orbit, the drug will undergo melt/cool experiments to grow new crystals. In about a month, the capsule will return to earth, landing at a US Air Force range in Utah. After a successful recovery, the material will be analyzed to learn how ritonavir crystals grown in space differ from those grown on earth.

Key Points: 
  • Within the capsule sits the drug ritonavir, created by scientists at Improved Pharma and housed in engineering designed and built by Varda to conduct controlled experiments in microgravity.
  • While in orbit, the drug will undergo melt/cool experiments to grow new crystals.
  • In 2021, Improved Pharma had the unique opportunity to start polymorph screening research projects in close collaboration with Varda Space Industries with the intent of advancing pharmaceutical manufacturing.
  • The research collaboration between Improved Pharma and Varda Space Industries will continue into future missions.

Rocket Lab Announces First Quarter 2023 Financial Results, Issues Guidance For Continued Growth In Second Quarter 2023

Retrieved on: 
Mardi, mai 9, 2023
Air, Technology, Satellite, Transport, Aerospace, Manufacturing, Neutron, Rocket Lab Launch Complex 1, NASA Launch Services Program, The Beat Goes On (Sonny & Cher song), Table, Lab, Rutherford, Capella Space, 3D, Starling, GAAP, Interest expense, Government, Phase 10, EBITDA, SSL (company), HawkEye 360, NASA, Hawk-Eye, Radio, Webcast, Varda Space Industries, Rocket Lab, TROPICS, Mid-Atlantic Regional Spaceport Launch Pad 0, Fireworks, Communications satellite, Beauty salon, Lithium, Mars, Electron, Spaceflight Industries, Photon

Rocket Lab USA, Inc. (Nasdaq: RKLB) (“Rocket Lab” or “the Company”), a global leader in launch services and space systems, today shared the financial results for fiscal first quarter 2023, ended March 31, 2023.

Key Points: 
  • Rocket Lab USA, Inc. (Nasdaq: RKLB) (“Rocket Lab” or “the Company”), a global leader in launch services and space systems, today shared the financial results for fiscal first quarter 2023, ended March 31, 2023.
  • Rocket Lab remains the only U.S. commercial small launch provider to successfully deliver satellites to orbit in 2023.
  • For the second quarter of 2023, Rocket Lab expects:
    Revenue between $60 million and $63 million.
  • ET) today to discuss these business highlights and financial results for our first quarter, to provide our outlook for the second quarter, and other updates.

Rocket Lab Completes Custom-Built Photon Spacecraft for Varda Space Industries

Retrieved on: 
Mardi, mai 9, 2023
Technology, Satellite, Other Technology, Aerospace, Manufacturing, Hardware, Health, Pharmaceutical, General Health, Varda Space Industries, Varda, Therapy, HIV, Rocket Lab Photon, Lab, System, Orbit, Spacecraft, Vandenberg Space Force Base, Multimedia, COVID, Ritonavir, NASA, Rocket, Rocket Lab, Software, Transport, Photon

Rocket Lab USA, Inc. (Nasdaq: RKLB) (“Rocket Lab” or “the Company”), a global leader in launch services and space systems, today announced it has completed and shipped a custom Photon spacecraft developed for Varda Space Industries (“Varda”), a leading in-space manufacturing and hypersonic re-entry logistics company.

Key Points: 
  • Rocket Lab USA, Inc. (Nasdaq: RKLB) (“Rocket Lab” or “the Company”), a global leader in launch services and space systems, today announced it has completed and shipped a custom Photon spacecraft developed for Varda Space Industries (“Varda”), a leading in-space manufacturing and hypersonic re-entry logistics company.
  • View the full release here: https://www.businesswire.com/news/home/20230509005556/en/
    Rocket Lab's Photon spacecraft integrated with Varda Space Industry's in-space manufacturing capsule.
  • The Photon spacecraft was developed, manufactured, and tested at Rocket Lab’s Spacecraft Production Facility in Long Beach, California.
  • A high energy variant of Photon was developed and launched by Rocket Lab in 2022, successfully deploying the CAPSTONE spacecraft to lunar orbit for NASA.